WHO ICTRP trial
Randomized study to evaluate the efficacy of therapy with Brentuximab…
EUCTR2019-002746-21-GR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-002746-21-GR |
|---|---|
| Public title | Randomized study to evaluate the efficacy of therapy with Brentuximab Vedotin-Etoposide, Methylprednisolone, Cisplatin and Cytarabine (ESHAP) vs ESHAP in patients with Hodgkin's Lymphoma, followed by treatment with Brentuximab Vedotin in patients who reach metabolic response after salvage therapy |
| Scientific title | A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with Brentuximab Vedotin-ESHAP vs ESHAP in Patients with Relapsed / Refractory Classical Hodgkin’s Lymphoma, Followed by Brentuximab Vedotin Consolidation (instead of Autologous Hematopoietic Stem Cell Transplantation) in Those who… |
| Primary sponsor | Grupo Español de linfomas y trasplante autologo de medula osea (GELTAMO) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Greece;Austria;Israel;Spain;Croatia |
| Conditions | Patients with Relapsed /Refractory Classical Hodgkin's Lymphoma MedDRA version: 20.1 Level: LLT Classification code 10080208 Term: Classical Hodgkin lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and… |
| Interventions | Trade Name: Adcetris Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: Brentuximab vedotin Other descriptive name: BRENTUXIMAB VEDOTIN Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Apr 18, 2022 |
| Target size | 150 |
| Secondary IDs | GELTAMO18-HL;2019-002746-21-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: